期刊文献+

Effect of anxiety after chemotherapy on antitumor immune response and tumor load in patients with advanced gastric cancer

下载PDF
导出
摘要 Objective:To study the effect of anxiety after chemotherapy on antitumor immune response and tumor load in patients with advanced gastric cancer.Methods:Patients with gastric cancer who received SOX chemotherapy in the First People's Hospital of Ziyang Sichuan Province between May 2012 and October 2015 were selected and divided into no anxiety group with HAMA score≤7 points, mild anxiety group with HAMA score 7-14 points, moderate anxiety group with HAMA score 14-21 points and severe anxiety group with HAMA score>21 points according to the HAMA score after four courses of chemotherapy. Cytokine and tumor marker levels in serum, immune cell levels in peripheral blood as well as proliferation gene expression in lesions were determined.Results: Peripheral blood Th1 levels as well as serum IL-2 and IFN-γ levels of mild anxiety group, moderate anxiety group and severe anxiety group were significantly lower than those of no anxiety group while peripheral blood Th2, Th17 and Treg levels as well as serum IL-4, IL-5, IL-17, IL-10, CEA, CA19-9, TK-1 and VEGF levels were significantly higher than those of no anxiety group, and EPHA2, c-myc and PCNA mRNA expression in tumor lesions were significantly higher than those of no anxiety group;the severer the anxiety, the lower the peripheral blood Th1 levels as well as serum IL-2 and IFN-γ levels, the higher the peripheral blood Th2, Th17 and Treg levels as well as serum IL-4, IL-5, IL-17, IL-10, CEA, CA19-9, TK-1 and VEGF levels, and the higher the EPHA2, c-myc and PCNA mRNA expression in tumor lesions.Conclusion:The aggravated anxiety in patients with advanced gastric cancer after chemotherapy will inhibit the antitumor immune response and increase the tumor load.
机构地区 Ultrasound Department
出处 《Journal of Hainan Medical University》 2017年第9期88-92,共5页 海南医学院学报(英文版)
  • 相关文献

参考文献1

二级参考文献18

  • 1DE MARTEL C, FERLAY J, FRANCESCHI S, et al. Globalburden of cancers attributable to infections in 2008: a reviewand synthetic analysis [ J ] . Lancet Oncol,2012,13(6): 607-615.
  • 2FERLAY J, SHIN H R, BRAY F, et al. Estimates ofWorldwide burden of cancer in 2008: GLOBOCAN 2008[J ] . Int J Cancer, 2010, 127(12): 2893-2917.
  • 3LI R, YUAN W, MEI W, et al. MicroRNA 520d-3p inhibitsgastric cancer cell proliferation, migration, and invasion bydownregulating EphA2 expression [ J ] . Mol Cell Biochem,2014, 396(1-2): 295-305.
  • 4TAPIA 0,RIQUELME I,LEAL P, et al. The PI3K/AKT/mTOR pathway is activated in gastric cancer with potentialprognostic and predictive significance [ J ] . Virchows Archiv,2014,465(1): 25-33.
  • 5YUAN W, CHEN Z, WU S,et al. Silencing of EphA2 inhibitsinvasion of human gastric cancer SGC-7901 cells in vitro andin vivo [ J ] . Neoplasm, 2011,59(1): 105-113.
  • 6HUANG J, XIAO D,LI G,et al. EphA2 promotes epithelial-mesenchymal transition through the Wnt/ (3 -catenin pathwayin gastric cancer cells [ J ] . Oncogene, 2014, 33(21): 2737-2747.
  • 7AL-BATRAN S E, DUCREUX M, OHTSU A. mTOR as atherapeutic target in patients with gastric cancer [ J ] . IntJ Cancer, 2012,130(3): 491-496.
  • 8ZHUANG G, BRANTLEY-SIEDERS D M, VAUGHT D,et al. Elevation of receptor tyrosine kinase EphA2 mediatesresistance to trastuzumab therapy [ J ] . Cancer Res, 2010,70(1): 299-308.
  • 9WILLEMS L, TAMBURINI J, CHAPUIS N, et al. PI3K andmTOR signaling pathways in cancer: New data on targetedtherapies [ J ] . Curr Oncol Rep, 2012, 14(2): 129-138.
  • 10POLIVKA J, JANKU F. Molecular targets for cancer therapyin the PI3K/AKT/mTOR pathway [ J ] . Pharmacol Therapeut,2014,142(2): 164-175.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部